DV Biomed Financials
| 6539 Stock | TWD 66.10 2.50 3.93% |
6539 |
Understanding current and past DV Biomed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of DV Biomed's financial statements are interrelated, with each one affecting the others. For example, an increase in DV Biomed's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in DV Biomed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DV Biomed Co. Check DV Biomed's Beneish M Score to see the likelihood of DV Biomed's management manipulating its earnings.
DV Biomed Stock Summary
DV Biomed competes with Prime Oil, Central Reinsurance, Phoenix Silicon, Chi Sheng, and Sports Gear. DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company was founded in 2011 and is based in Taipei, Taiwan. UnicoCell operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| Business Address | No 63, Xingai |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.dvbiomed.com |
| Phone | 886 2 2791 1826 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in DV Biomed without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of 6539 Stock, because this is throwing your money away. Analyzing the key information contained in DV Biomed's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
DV Biomed Key Financial Ratios
There are many critical financial ratios that DV Biomed's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that DV Biomed reports annually and quarterly.6539 Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DV Biomed's current stock value. Our valuation model uses many indicators to compare DV Biomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DV Biomed competition to find correlations between indicators driving DV Biomed's intrinsic value. More Info.DV Biomed Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DV Biomed Co is roughly 2.66 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DV Biomed's earnings, one of the primary drivers of an investment's value.DV Biomed Systematic Risk
DV Biomed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. DV Biomed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on DV Biomed correlated with the market. If Beta is less than 0 DV Biomed generally moves in the opposite direction as compared to the market. If DV Biomed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one DV Biomed is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of DV Biomed is generally in the same direction as the market. If Beta > 1 DV Biomed moves generally in the same direction as, but more than the movement of the benchmark.
DV Biomed March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of DV Biomed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DV Biomed Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of DV Biomed Co based on widely used predictive technical indicators. In general, we focus on analyzing 6539 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DV Biomed's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.44 | |||
| Information Ratio | 0.052 | |||
| Maximum Drawdown | 9.08 | |||
| Value At Risk | (4.45) | |||
| Potential Upside | 4.77 |
Additional Tools for 6539 Stock Analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.